• Login
    View Item 
    •   UMB Digital Archive
    • School, Graduate
    • Theses and Dissertations All Schools
    • View Item
    •   UMB Digital Archive
    • School, Graduate
    • Theses and Dissertations All Schools
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of UMB Digital ArchiveCommunitiesPublication DateAuthorsTitlesSubjectsThis CollectionPublication DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    Display statistics

    Cost and Management of Fractures in Medicare Beneficiaries with Non-Metastatic Prostate Cancer Treated with Androgen Deprivation Therapy

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Yong_umaryland_0373D_10659.pdf
    Size:
    17.72Mb
    Format:
    PDF
    Download
    Author
    Yong, Candice
    Advisor
    Onukwugha, Eberechukwu
    Date
    2015
    Type
    dissertation
    
    Metadata
    Show full item record
    Abstract
    Background: Androgen deprivation therapy (ADT) in prostate cancer (PCa) is associated with increased fracture risk and costs. There is limited information regarding the use of guideline-recommended bone mineral density (BMD) testing and bisphosphonate therapy. This study examined patient-specific (e.g., comorbidity) and non-patient-specific (e.g., physician specialist visits) factors associated with BMD testing, bisphosphonate therapy, fracture risk, and costs. Methods: This retrospective cohort analysis used linked Surveillance, Epidemiology, and End Results & Medicare data on men aged 65+ with non-metastatic PCa and treated with ADT. Cox proportional hazards models examined the association between baseline Charlson Comorbidity Index (CCI) and fracture, accounting for death as a competing risk. Partitioned weighted least squares regression models quantified the 5-year incremental cost of fractures. Multivariable logistic regression models quantified the effect of specialist visits on BMD testing and bisphosphonate use. Results: Of 30,904 men, 6,779 (22%) had a fracture during 5-years of follow-up. Among men aged 66-74 years, the sub-hazard ratio (SHR) (95% CI) for fracture was 1.17 (1.05-1.29) for CCI=1 and 1.69 (1.51-1.90) for CCI=2+ (reference: CCI=0); CCI was not associated with fracture risk among the oldest men aged 85+ years. The mean (95% CI) incremental cost of fractures was $31,800 ($31,709-$31,891), $34,320 ($34,152-$34,488), and $46,678 ($46,534-$46,822) among patients with CCI=0, CCI=1, and CCI=2+, respectively. Following ADT initiation, 17.9% received BMD testing and 9.6% received bisphosphonate. Compared to men who saw a urologist and primary care physician, bisphosphonate receipt was more likely among men with a urologist and medical oncologist involved in their care (AOR=1.89; 95% CI=1.38-2.57), and less likely among men who saw a urologist and radiation oncologist (AOR=0.63; 95% CI=0.42-0.95). There were no statistically significant associations between specialist visits and BMD testing. Conclusions: Patients with greater comorbidity burden had increased fracture risk and higher costs associated with fractures. These patients could benefit from regular monitoring of BMD and bisphosphonate therapy, which occurred in approximately 2 in 10 men. Involving certain types of specialists (e.g., medical oncologists) in the management of men with PCa could be beneficial for bone health management.
    Description
    University of Maryland, Baltimore. Pharmaceutical Health Services Research. Ph.D. 2015
    Keyword
    androgen deprivation therapy
    bone health management
    bone loss
    Prostate--Cancer
    Cost
    Fractures, Bone
    Identifier to cite or link to this item
    http://hdl.handle.net/10713/4851
    Collections
    Theses and Dissertations School of Pharmacy
    Theses and Dissertations All Schools

    entitlement

     
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Policies | Contact Us | UMB Health Sciences & Human Services Library
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.